Amphion Innovations PLC Director/PDMR Shareholding (1354S)
December 16 2016 - 10:07AM
UK Regulatory
TIDMAMP
RNS Number : 1354S
Amphion Innovations PLC
16 December 2016
Amphion Innovations plc
("Amphion" or "the Company")
Directors Dealings
London and New York, 16 December 2016 - Amphion Innovations plc
(AIM: AMP), the developer of medical, life science, and technology
businesses, announces that on 15 December 2016 it granted options
over ordinary shares in the Company ("Options") to certain of its
Directors as follows:
Director Amount Strike Vesting
Price
------------------- -------- ----------- -------------------
Paul Kennedy 400,000 2.12 pence Monthly over
a 36 month period
------------------- -------- ----------- -------------------
Miroslaw Izienicki 281,250 2.12 pence Monthly over
a 30 month period
------------------- -------- ----------- -------------------
All Options commence vesting backdated from 1 August 2016.
The strike price is based on the closing price on 15 December
2016, and the Options are exercisable on the date of vesting.
Authority for the allotment of ordinary shares under the Share
Option Scheme has already been given by the Shareholders in general
meeting.
For further information please contact:
Amphion Innovations
Charlie Morgan
+1 212 210 6224
Yellow Jersey PR
Charles Goodwin / Dominic Barretto
+44 (0)7747 788 221
Panmure Gordon Limited (Nominated Adviser and Corporate
Broker)
Freddy Crossley / Duncan Monteith (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 (0)20 7886 2500
Northland Capital Partners Limited (Joint Corporate Broker)
Patrick Claridge / David Hignell (Corporate Finance)
John Howes (Corporate Broking)
+44 (0)20 3861 6625
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and
technology businesses.
We use our extensive experience in company building to invest
and build shareholder value in high growth companies in the US and
UK. Amphion has significant shareholding in 7 Partner Companies
developing proven technologies targeting substantial commercial
marketplaces. The Amphion model has been refined to optimise the
commercialisation of patents and other intellectual property within
the Partner Companies. The Partner Companies collectively own or
control over 200 separately identified pieces of intellectual
property, a number which grows rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEQLFFQLFBFBQ
(END) Dow Jones Newswires
December 16, 2016 10:07 ET (15:07 GMT)
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2023 to Apr 2024